AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05564754 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Fever control without a device
Description: Management of fever in the ICU without a device
Study NCT04717765 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Preventive, LLL Phototherapy and topical Vit E
Description: Interventions will be carried out for patients who have already passed or will undergo anti-neoplastic chemotherapy or radiation therapy.
Study NCT04717765 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Preventive, LLL Phototherapy and topical Vit E
Description: Interventions will be carried out for patients who have already passed or will undergo anti-neoplastic chemotherapy or radiation therapy.
Study NCT04717765 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Curative, LLL Phototherapy and topical Vit E
Description: Interventions will be carried out for patients who have already passed or will undergo anti-neoplastic chemotherapy or radiation therapy.
Study NCT04717765 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Curative, LLL Phototherapy and topical Vit E
Description: Interventions will be carried out for patients who have already passed or will undergo anti-neoplastic chemotherapy or radiation therapy.
Study NCT04717765 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Preventive, LLL Phototherapy and LPRF
Description: Interventions will be carried out for patients who have already passed or will undergo anti-neoplastic chemotherapy or radiation therapy.
Study NCT04717765 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Preventive, LLL Phototherapy and LPRF
Description: Interventions will be carried out for patients who have already passed or will undergo anti-neoplastic chemotherapy or radiation therapy.
Study NCT04717765 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Curative, LLL Phototherapy and LPRF
Description: Interventions will be carried out for patients who have already passed or will undergo anti-neoplastic chemotherapy or radiation therapy.
Study NCT04717765 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Curative, LLL Phototherapy and LPRF
Description: Interventions will be carried out for patients who have already passed or will undergo anti-neoplastic chemotherapy or radiation therapy.
Study NCT05288712 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Training protocol with the device cervical for treatment (CDAT)
Description: Training protocol with the cervical device for treatment (CDAT)
Study NCT06515678 — intervention group
Intervention type: DRUG
Intervention: arm A - angiotensin converting enzyme inhibitors (ACEi)
Description: Patients with ACEi monotherapy before or within 6 months following debulking surgery.~ACEi will be defined as any drugs from the Anatomical Therapeutic Classification C09AA with an indication for hypertension, including but not limited to: captopril, enalapril, lisinopril, perindopril, ramipril, quinapril
Study NCT06515678 — intervention group
Intervention type: DRUG
Intervention: arm B - calcium channel blockers (CCBs)
Description: Patients with CCB monotherapy before or within 6 months following debulking surgery.~CCBs will be defined as any drugs from the Anatomical Therapeutic Classification C08CA with an indication for hypertension, including but not limited to: amlodipine, felodipine, isradipine, nicardipine, nifedipine
Study NCT06515678 — intervention group
Intervention type: DRUG
Intervention: arm R - angiotensin receptor blockers ARB
Description: Patients with angiotensin receptor blocker (ARB) before or within 6 months following debulking surgery.~ARBs will be defined as any drugs from the Anatomical Therapeutic Classification C09CA with an indication for hypertension, including but not limited to: losartan, valsartan, irbesartan, candesartan or olmesartan medoxomil.
Study NCT05564754 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Low MAP
Description: A MAP target of >65mmHg will be used. Vasopressors will be titrated to this target during 36h.
Study NCT05564754 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Minimal sedation
Description: A strategy of minimal sedation in the ICU, used only as needed to facilitate transport, imaging and invasive procedures.
Study NCT05756894 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Neurostimulation
Description: Paired stimulation will be given to the spinal cord and to peripheral nerves so that the signals are received at the spinal cord at a specific interval.
Study NCT05756894 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Repiratory training
Description: Respiratory exercises will be completed immediately after completing neurostimulation. Respiratory exercises will involve inspiratory muscle training performing four sets of 6-10 breaths per day with two minutes of rest.
Study NCT05265936 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Passing a guidewire through a double j stent
Description: The previously placed double J stent is removed up to the urethral meatus with a cystoscope and forceps and kept fixed at the meatal level without further pulling. Then, after reaching the kidney by passing a guidewire through it, the double j stent is removed. Followed by the routine lithotripsy procedure.
Study NCT05265936 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Double J stent removal and guidewire insertion
Description: The double j stent is completely removed with the cystoscope and forceps, and the guidwire is inserted into the ureter by visualizing it with the cystoscope. Followed by the routine lithotripsy procedure.
Study NCT05956262 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: AR-toothbrush machine
Description: Student in AR group received a two-time repeated AR-based training for 30 minutes at two-week intervals. The AR-based training system (PVIX Oral, EPED) digitized the steps of the toothbrushing technique applying optical tracking technology to enable the participants to obtain immediate scoring after the completion of practice. The scoring depends on the level of removing simulated dental plaque. The AR system was equipped with an optical tracking unit, a 3D training head model, and a wireless toothbrush. The toothbrushing practice time for the upper and lower jaw is 3 minutes, respectively. A tooth-brushing song played while the students implemented.
Study NCT05956262 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Teach proper brushing skills
Description: Students in the traditional group received a two-time repeated 10-minute lesson regarding proper toothbrushing skills in the classroom at two-week intervals. The students were taught by a well-trained dental hygienist using teaching aids (such as dental models, and toothbrushes).
Study NCT05094570 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dupilumab Prefilled Syringe
Description: Dupilumab 300 mg
Study NCT05038436 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Polyglucosamine L112
Description: Two tablets once daily per os
Study NCT05038436 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Polyglucosamine L112
Description: Two tablets once daily per os
Study NCT05475795 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Metapex
Description: obturation of root canals of primary molars with Metapex
Study NCT05475795 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Metapex
Description: obturation of root canals of primary molars with Metapex
Study NCT05475795 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Endoflas
Description: obturation of root canals of primary molars with Endoflas
Study NCT05475795 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Endoflas
Description: obturation of root canals of primary molars with Endoflas
Study NCT06505434 — intervention group
Intervention type: PROCEDURE
Intervention: Cataract surgery
Description: Phaco + IOL Implantation
Study NCT05378204 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Main study:
Description: For each included patient, tumor biopsy specimen and blood samples will be collected at baseline visit (before the first dose of PARPi treatment).~During the treatment period: blood samples will be scheduled every 8 weeks (i.e. 2 cycles).~At the time of progression: tumor biopsy and blood samples will be collected.
Study NCT05378204 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Sub-study:
Description: For each included patient, tumor biopsy specimen and blood samples will be collected as soon as possible after progression (before initiation of the post PARPi anti-tumoral treatment).
Study NCT05165901 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Scrambler Therapy
Description: LG Medipain is a type of non-invasive neuromodulation.
Study NCT04813198 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: TIPSTART
Description: TIPSTART is a multimodal, cognitive behavior-based therapy integrating peer-sharing, technology, aerobic and resistance training.
Study NCT05052762 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Group A: Elastic resisted training for Gluteus Maximus strength
Description: Subjects attended physical therapy two times per week for a total of 10 visits. In the first five sessions, subjects performed the following exercises to strengthen the gluteus maximus: bilateral bridge, unilateral bridge, and non-weight-bearing hip extension in prone with the knee flexed at 90 degrees. In the next five sessions, abduction and external rotation in a quadruped (fire hydrant exercise) and weight-bearing hip extension (known as deadlift exercise) are added. Each exercise was performed for 10 repetitions. Elastic resistance was Added to the fire hydrant, hip extension in prone and deadlift exercises to allow each subject to perform at a 10-repetition maximum. The resistance for each subject was adjusted weekly as needed. The exercise program was performed under direct supervision only during the physical therapy sessions.
Study NCT05052762 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Group B: Weight resisted training for Gluteus Maximus strength
Description: Subjects attended p two times per week for a total of 10 visits. The participants performed PHEKF in 90° knee flexion with 30° hip abduction and 10° hip extension to increase the muscle activity of the gluteus maximus. In the prone position, the participant performed 10° hip extension until the posterior knee reached the horizontal bar. The participants maintained 90° knee flexion with 30° hip abduction and 10° hip extension in the prone position against the resistance. Sandbags (3 kg) will be used to provide resistance on the ankle through a rope and pulley. Each subject performed three sets with three repetitions of five seconds each. 1-minute break is allowed between each set.
Study NCT05148598 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: ADRCs
Description: Adipose Derived Regenerative Cells (ADRCs) processed with Celution System
Study NCT05148598 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Standard Care
Description: Standard care
Study NCT05148598 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Standard Care
Description: Standard care
Study NCT05148598 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo visually indistinguishable from ADRCs
Study NCT05907772 — intervention group
Intervention type: OTHER
Intervention: No intervention
Description: No intervention
Study NCT06231004 — intervention group
Intervention type: PROCEDURE
Intervention: glucocorticosteroid and surgery
Description: Take glucocorticosteroid at once in the morning and use the following course of treatment: 6 tablets/day for 7 days-- 5 tablets/day for 2 days-- 4 tablets/day for 2 days-- 3 tablets/day for 2 days-- 2 tablets/day for 2 days-- 1 tablets/day for 2 days--surgery
Study NCT00664690 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: celebrex
Description: 400 mg celebrex given 1 hour preop and celebrex 200 mg BID postop
Study NCT06057935 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pemetrexed
Description: Pemetrexed will be administered intravenously
Study NCT06057935 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Pemetrexed
Description: Pemetrexed will be administered intravenously
Study NCT06057935 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cisplatin
Description: Cisplatin will be administered intravenously
Study NCT06057935 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Cisplatin
Description: Cisplatin will be administered intravenously
Study NCT06057935 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carboplatin
Description: Possible substitution with carboplatin based on clinician discretion
Study NCT04690998 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Blood Samples
Description: Genetic, proteomic, neurofilament analysis
Study NCT04690998 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: MRI
Description: Spinal and muscular MRI
Study NCT05363644 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: BioDFence G3
Description: Placement of a sheet of BioDFence® G3 will be applied to the neurovascular bundle on participants undergoing an elective Full Nerve Sparing Radical Prostatectomy for primary treatment of prostate cancer.
Study NCT00664690 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: placebo given preop and BID postop
Study NCT06289998 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tamibarotene
Description: Subjects are administrated to tamibarotene 4 mg in daily for 52 weeks.
Study NCT06289998 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Subjects are administrated to placebo in daily for 52 weeks.
Study NCT06341842 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dapagliflozin 10mg Tab
Description: Dapaglifloziin 10 mg 1 tab daily
Study NCT04673864 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CKD-386
Description: QD, PO
Study NCT06379880 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: CONTINUUM+ CONNECT remote monitoring
Description: CONTINUUM+ CONNECT is a web platform, accessible via the internet, which contains the digital medical device (DMN) Continuum+ alert module. This is a medical software intended for the interpretation of clinical constants, symptoms, adverse events and pain, generating alerts with a view to improving the monitoring of patients undergoing anticancer treatment. The Continuum+ Alert Module version 1.0.0 dated 30 April 2021 is CE-marked and will be used in accordance with the manufacturer's instructions for use by patients in the experimental group.
Study NCT04718610 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Osteopathic intervention
Description: Nerve vagus stimulation
Study NCT04718610 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: CRP assessment
Description: Blood CRP will be assessed during trial
Study NCT04718610 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: CRP assessment
Description: Blood CRP will be assessed during trial
Study NCT04718610 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: QLQ-C30 questionnaire
Description: Completion of QLQ-C30
Study NCT04718610 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: QLQ-C30 questionnaire
Description: Completion of QLQ-C30
Study NCT05295342 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: No Means No intervention Girls' Curriculum
Description: The No Means No (NMN) Girls' Curriculum is a violence prevention program designed for adolescent girls and young women 10-20 years old. This curriculum has been designed specifically for safer implementation during the COVID-19 pandemic. NMN Girls' programming is deeply rooted in Empowerment Self-Defense, which is a uniquely holistic, survivor-centered, feminist approach to self-protection skills. Youth educators called Instructors deliver the curriculum to young people in schools. This 8-hour intervention is comprised of classes that teach young people mental, verbal and physical self-defense skills that can be used to prevent sexual assault and other forms of gender-based violence.
Study NCT05295342 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: No Means No intervention Boys' Curriculum
Description: The No Means No (NMN) Boys' Curriculum is a violence prevention curriculum that has been designed specifically for implementation during the COVID-19 pandemic. Designed for adolescent boys and young men age 10-20. Like the girls program it is delivered by youth educators called Instructors in schools. This 8-hour intervention is comprised of classes that teach young people gender equitable attitudes, skills to defend equality and how to avoid violence as a power paradigm.
Study NCT05295342 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Active comparator: Life Orientation
Description: The standard school-based Life Orientation curriculum
Study NCT04673864 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: D012, D326, D337
Description: QD, PO
Study NCT05288712 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional training protocol
Description: Conventional training protocol
Study NCT04475835 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bivalirudin
Description: Bivaliruding 0.75 mg/kg intravenous bolus loading dose, and immediately followed by intravenous infusion of 1.75 mg/kg/h until 4 hours after PCI. A prolonged infusion of 0.2 mg/kg/h for ≤20h could be considered at the operator's discretion. It is recommended that ACT be monitored 5 minutes after the first administration, and if ACT is \<225 s (Hemotec method), intravenous injection of 0.30 mg/kg of bivalirudin should be administered.
Study NCT04475835 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Heparin
Description: Heparin is dosed at 100 U/kg. ACT is monitored 5 min after the first administration, and if the ACT \<225 s (Hemotec method), an intravenous injection of heparin should be administered by need.
Study NCT06154694 — intervention group
Intervention type: RADIATION
Intervention: Stereo Radiographic EOS Measurements
Description: Healthy control will undergo a stereo radiographic EOS exam with their arm in various positions.~1. Relaxed standing (0 degree of abduction)~2. 45 degree of abduction in the coronal plane~3. 90 degree of abduction in the coronal plane~4. 120 degree of abduction in the coronal plane~5. 45 degree anterior flexion in the sagittal plane~6. 90 degree anterior flexion in the sagittal plane~7. 120 degree of anterior flexion in the sagittal plane~8. 45 degree extension in the sagittal plane
Study NCT06400277 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Edentulous maxilla final impression for complete denture
Description: Final impressions of edentulous maxilla separated in two groups. In physical impression group stock and individual trays and physical impression materials used.
Study NCT05567263 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Bulk-fill resin composite, (3M, ESPE)
Description: Teeth will be restored with Bulk-fill resin composite, (3M, ESPE)
Study NCT05567263 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Surefil one™ Self-Adhesive Composite Hybrid
Description: teeth will be restored with Surefil one™ Self-Adhesive Composite Hybrid
Study NCT06476951 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Parent-Child Physical Activity Program
Description: The program includes online education, parent-child games, parent-child dancing, and other parent-child physical activity activities.
Study NCT06255158 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: INSIGHT Program
Description: INSIGHT Program:~the program targets the reduction of EMSs' interference in social information processing, which may otherwise lead to the use of deviant behavior to fulfill emotional and sexual needs. Furthermore, the program has specific goals: (1) developing insight about the offense cycle; (2) fostering empathy for victims; (3) enhancing intimate and social/ interpersonal skills; (4) increasing emotional regulation skills.
Study NCT06255158 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Treatment As Usual (TAU)
Description: TAU in Portuguese prisons is primarily aimed to increase educational and professional qualifications
Study NCT06417294 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 3D health education model
Description: explanation combined with 3D printed health education model
Study NCT06417294 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: traditional education
Description: Regular education
Study NCT06408077 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Water administration
Description: Intravenous administration of water (Aqua ad injectabilia) until a decrease of plasma sodium of 5 to 8 mmol/l has been achieved
Study NCT06214338 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Low dose
Description: Consumption of a β-alanine sustained-release supplement, 10 mg by 4 intakes of 2.5, separated by 1 hour and 15 min.
Study NCT06214338 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: High dose
Description: Consumption of a β-alanine sustained-release supplement, 10 mg by 4 intakes of 5 separated by 1 hour and 15 min.
Study NCT05070299 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Psychosexual Educational Partner Program (PEPP)
Description: A communication and intimacy promotion kit consisting of three modules devoted to information sharing, partner communication and activities for building intimacy.
Study NCT05654662 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Corsodyl Original Dentifrice
Description: It contains 67% weight/weight (w/w) Sodium Bicarbonate and 0.310% w/w Sodium Fluoride (1400 parts per million \[ppm\] Fluoride ion \[F\])